Screener
NeoGenomics NEO Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | (unaudited)June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current assets | ||
| Cash and cash equivalents | $145,539 | $159,618 |
| Accounts receivable, net | 175,405 | 159,242 |
| Inventories | 27,137 | 28,566 |
| Prepaid assets | 23,590 | 21,443 |
| Other current assets | 9,807 | 7,417 |
| Total current assets | 381,478 | 376,286 |
| Property and equipment (net of accumulated depreciation of $223,479 and $209,057, respectively) | 80,938 | 84,834 |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's inventories?
- NeoGenomics (NEO) reported inventories of $27.14M in Q2 2026.
- How has NeoGenomics's inventories changed year-over-year?
- NeoGenomics's inventories decreased by 20.6% year-over-year, from $34.17M to $27.14M.
- What is the long-term trend for NeoGenomics's inventories?
- Over 5 years (2020 to 2025), NeoGenomics's inventories has grown at a -0.7% compound annual growth rate (CAGR), from $29.53M to $28.57M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.
Ask your AI about NeoGenomics's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude